Back to Polar Capital Holdings Plc

REGN
Showing 8 of 22 quarters

Position history for Polar Capital Holdings Plc's holdings in REGENERON PHARMACEUTICALS

Polar Capital Holdings Plc holds 192,546 shares of REGN (REGENERON PHARMACEUTICALS), worth $148.8M as of 2026-Q1. The position was decreased (-6.0% shares). REGN represents 0.5% of Polar Capital Holdings Plc's portfolio.

Current Value

$148.8M

Current Shares

192,546

Total Value Change

+$8.9M

Total Shares Change

+59,515

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Decreased
192,546
-6.0%
$148.8M0.5%$766.66
0
2025-Q4
Increased
204,927
+29.0%
$158.2M0.6%$773.94
54
2025-Q3
Increased
158,817
+126.9%
$89.3M0.4%$560.05
58
2025-Q2
Increased
70,000
+27.3%
$36.8M0.2%$519.56
43
2025-Q1
Decreased
55,000
-2.2%
$34.9M0.2%$634.66
0
2024-Q4
Decreased
56,249
-21.6%
$40.1M0.2%$698.71
0
2024-Q3
Decreased
71,795
-46.0%
$75.5M0.4%$1,036.94
0
2024-Q2
Decreased
133,031
-24.8%
$139.8M0.8%$1,045.23
0

Other major holders of REGN: VANGUARD GROUP INC, BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used